Skip to content
Alvotech icon

Alvotech

ALVOStocksBiotechnologyLuxembourgNasdaqUSD

Price

$5.84

Today

-0.7%

YTD

+15.0%

About

Alvotech works within the global biopharmaceuticals field, creating biosimilar medicines that increase patient accessibility by reducing healthcare costs across Europe, North America, and Asia. Operating in the biopharmaceutical sector, Alvotech offers services in the development, manufacturing, and commercialisation of biosimilar products. This growing company has a biosimilar manufacturing facility, alongside a deep pipeline of products making notable strides in the health sector, boosted further by a selection of strategic partnerships. Alvotech is a subsidiary of Alvogen. Diversify your virtual portfolio by following ALVO shares on eToro.

Price chart
Closing price history for ALVO (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-12.43
P/S (TTM)1.94
P/B (TTM)-3.84
Market cap$1.11B
Cap tierSmall-cap
Industry avg P/E-6.15

Profitability

Gross margin61.35%
EBIT margin13.35%
Net margin0.97%
ROEUnknown
ROA-6.05%

Earnings & Revenue

Revenue (TTM)$559.42M
Revenue growth (1Y)-4.5%
EPS (TTM)-$0.26
Free cash flow$-171.60M
Total debt$1.46B

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.75
Employees1,460
Next earnings11 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Alvotech (ALVO) | Dirk Kuyken